Literature DB >> 15139766

Design, synthesis, and biological evaluation of hybrid molecules containing alpha-methylene-gamma-butyrolactones and polypyrrole minor groove binders.

Pier Giovanni Baraldi1, Maria Del Carmen Nunez, Mojgan Aghazadeh Tabrizi, Erik De Clercq, Jan Balzarini, Jaime Bermejo, Francisco Estévez, Romeo Romagnoli.   

Abstract

We have synthesized and evaluated a series of hybrids of polypyrrole minor groove binders structurally related to the natural antitumor agent distamycin A, and alpha-methylene-gamma-butyrolactones with methyl, phenyl, and 4-substituted phenyl groups at the lactone C(gamma) position, denoted 5-17, for in vitro cytotoxic activity against a variety of cancer cell lines. The apoptotic and cytotoxic activities against several tumor cell lines are reported and discussed in terms of their structural differences in relation to both the number of N-methylpyrrole rings and the type of the alkylating unit tethered to the oligopeptidic frame. It may be noted that in general, and especially for 11, 12, and 17, the cytotoxicity of the hybrids was much greater than that of the alpha-methylene-gamma-butyrolactone units 24a-g alone. Using the human leukemia cell line HL-60, we have tested the effects of a selected series of compounds on programmed cell death (apoptosis). The results clearly indicate that 11, 12, and 17, but not 9, are able to induce apoptosis as demonstrated from (i) identification of nuclear changes associated with apoptosis using fluorescence microscopy and (ii) by DNA laddering on agarose gel electrophoresis. Compound 12 was the most potent, especially after a short incubation period. It induced extensive hydrolysis of poly ADP-ribose polymerase (PARP), considered to be a hallmark of apoptosis, which plays a critical role in chromatin architecture and DNA metabolism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15139766     DOI: 10.1021/jm031104y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  Bis[3,5-bis(benzylidene)-4-oxo-1-piperidinyl]amides: a novel class of potent cytotoxins.

Authors:  Swagatika Das; Umashankar Das; Armando Varela-Ramírez; Carolina Lema; Renato J Aguilera; Jan Balzarini; Erik De Clercq; Stephen G Dimmock; Dennis K J Gorecki; Jonathan R Dimmock
Journal:  ChemMedChem       Date:  2011-08-08       Impact factor: 3.466

2.  E,E-2-Benzylidene-6-(nitrobenzylidene)cyclohexanones: syntheses, cytotoxicity and an examination of some of their electronic, steric, and hydrophobic properties.

Authors:  Umashankar Das; Alireza Doroudi; Swagatika Das; Brian Bandy; Jan Balzarini; Erik De Clercq; Jonathan R Dimmock
Journal:  Bioorg Med Chem       Date:  2008-04-16       Impact factor: 3.641

3.  Novel 3,5-bis(arylidene)-4-oxo-1-piperidinyl dimers: structure-activity relationships and potent antileukemic and antilymphoma cytotoxicity.

Authors:  Yahaira Santiago-Vazquez; Swagatika Das; Umashankar Das; Elisa Robles-Escajeda; Nora M Ortega; Carolina Lema; Armando Varela-Ramírez; Renato J Aguilera; Jan Balzarini; Erik De Clercq; Stephen G Dimmock; Dennis K J Gorecki; Jonathan R Dimmock
Journal:  Eur J Med Chem       Date:  2014-03-06       Impact factor: 6.514

4.  2-(3-Aryl-2-propenoyl)-3-methylquinoxaline-1,4-dioxides: a novel cluster of tumor-specific cytotoxins which reverse multidrug resistance.

Authors:  Umashankar Das; Hari N Pati; Atulya K Panda; Erik De Clercq; Jan Balzarini; Joseph Molnár; Zoltán Baráth; Imre Ocsovszki; Masami Kawase; Li Zhou; Hiroshi Sakagami; Jonathan R Dimmock
Journal:  Bioorg Med Chem       Date:  2009-04-17       Impact factor: 3.641

5.  1-Arylmethyl-2,3-dioxo-2,3-dihydroindole thiosemicarbazones as leads for developing cytotoxins and anticonvulsants.

Authors:  Subhas S Karki; Vivek Singh Bahaduria; Vivek Rana; Sujeet Kumar; Prasanna G Subbaro; Umashankar Das; Jan Balzarini; Erik De Clercq; Jonathan R Dimmock
Journal:  J Enzyme Inhib Med Chem       Date:  2009-04       Impact factor: 5.051

6.  The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4-bis(benzylidene)-8-methyl-8-azabicyclo[3.2.1] octan-3-ones and 3,5-bis(benzylidene)-1-methyl-4-piperidones.

Authors:  Hari N Pati; Umashankar Das; Swagatika Das; Brian Bandy; Erik De Clercq; Jan Balzarini; Masami Kawase; Hiroshi Sakagami; J Wilson Quail; James P Stables; Jonathan R Dimmock
Journal:  Eur J Med Chem       Date:  2008-03-29       Impact factor: 6.514

7.  Design, synthesis and antiproliferative activity of some 3-benzylidene-2,3-dihydro-1-benzopyran-4-ones which display selective toxicity for malignant cells.

Authors:  Pal Perjési; Umashankar Das; Erik De Clercq; Jan Balzarini; Masame Kawase; Hiroshi Sakagami; James P Stables; Tamas Lorand; Zsuzsanna Rozmer; Jonathan R Dimmock
Journal:  Eur J Med Chem       Date:  2007-07-10       Impact factor: 6.514

8.  1-Aryl-2-dimethylaminomethyl-2-propen-1-one hydrochlorides and related adducts: A quest for selective cytotoxicity for malignant cells.

Authors:  Hari N Pati; Umashankar Das; Masami Kawase; Hiroshi Sakagami; Jan Balzarini; Erik De Clercq; Jonathan R Dimmock
Journal:  Bioorg Med Chem       Date:  2008-03-27       Impact factor: 3.641

9.  3,5-Bis(benzylidene)-4-oxo-1-phosphonopiperidines and related diethyl esters: Potent cytotoxins with multi-drug-resistance reverting properties.

Authors:  Swagatika Das; Umashankar Das; Ponniah Selvakumar; Rajendra K Sharma; Jan Balzarini; Erik De Clercq; Joseph Molnár; Julianna Serly; Zoltán Baráth; Gabriele Schatte; Brian Bandy; Dennis K J Gorecki; Jonathan R Dimmock
Journal:  ChemMedChem       Date:  2009-11       Impact factor: 3.466

10.  Enantioselective synthesis of beta-(3-hydroxypyrazol-1-yl) ketones using an organocatalyzed Michael addition reaction.

Authors:  Sanjib Gogoi; Cong-Gui Zhao; Derong Ding
Journal:  Org Lett       Date:  2009-06-04       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.